ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - oxaliplatin 5 mg/ml - concentrate for solution for infusion - oxaliplatin - in combination with 5- fluorouracil and folinic acid (fa), oxaliplatin is indicated for: - adjuvant treatment of stage iii ( duke's c) colon cancer after complete resection of primary tumour - the treatment of metastatic colorectal cancer.

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - buserelin acetate 6.6 mg - rods for implant - buserelin - treatment of advanced hormone - dependent prostatic carcinoma.

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - buserelin acetate - קנים להשתלה - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - buserelin as acetate 0.1 mg/actuations - solution - buserelin - treatment of advanced hormone dependent prostatic carcinoma. endometriosis. use in ivf. precocious puberty. leyomyoma uteri.

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi israel ltd - insulin glargine - תמיסה להזרקה - insulin glargine 300 u/ml - insulin glargine

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - lixisenatide - תמיסה להזרקה - lixisenatide 10 mcg / 0.2 ml - lixisenatide

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi - aventis israel ltd - lixisenatide - תמיסה להזרקה - lixisenatide 20 mcg / 0.2 ml - lixisenatide

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi israel ltd - insulin glargine; lixisenatide - תמיסה להזרקה - lixisenatide 33 mcg / 1 ml; insulin glargine 100 units / 1 ml - insulin glargine

ইস্রায়েল - হিব্রু - Ministry of Health

sanofi israel ltd - insulin glargine; lixisenatide - תמיסה להזרקה - lixisenatide 50 mcg / 1 ml; insulin glargine 100 units / 1 ml - insulin glargine